blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1904029

EP1904029 - ORAL, QUICKLY DISINTEGRATING FILM, WHICH CANNOT BE SPIT OUT, CONTAINING OLANZAPIN [Right-click to bookmark this link]
Former [2008/14]ORAL, QUICKLY DISINTEGRATING FILM, WHICH CANNOT BE SPIT OUT, FOR A NEUROLEPTIC DRUG
[2010/36]
StatusPatent maintained as amended
Status updated on  10.10.2014
Database last updated on 04.06.2024
Most recent event   Tooltip24.04.2015Change - lapse in a contracting state
New state(s): CZ, LU, MC		published on 27.05.2015  [2015/22]
Applicant(s)For all designated states
Hexal AG
Industriestrasse 25
83607 Holzkirchen / DE
[2014/46]
Former [2011/04]For all designated states
Hexal AG
Industriestrasse 25
83607 Holzkirchen / DE
Former [2008/14]For all designated states
HEXAL AG
Industriestrasse 25
83607 Holzkirchen / DE
Inventor(s)01 / OBERMEIER, Petra
Rahel-Straus-Weg 8
81673 München / DE
02 / KOHR, Thomas
Gaisbergstrasse 18
81675 München / DE
03 / KRAMER, Kai-Thomas
Am Lettenholz 6
83646 Bad Tölz / DE
04 / KLOKKERS, Karin
Bahnhofstrasse 33
83677 Reichersbeuern / DE
 [2008/23]
Former [2008/14]01 / OBERMEIER, Petra
Rahel-Straus-Weg 8
81673 München / DE
02 / KOHR, Thomas
Gaisbergstrasse 18
81675 München / DE
03 / KRAMER, Kai-Thomas
Am Lettenholz 6
83646 Bad Tölz / DE
04 / KLOKKERS, Karin
Eichenstr. 2a
83620 Feldkirchen-Westerham / DE
Representative(s)Weiss, Wolfgang
Weickmann & Weickmann
Patent- und Rechtsanwälte PartmbB
Postfach 860 820
81635 München / DE
[N/P]
Former [2012/18]Weiss, Wolfgang
Weickmann & Weickmann Patentanwälte Postfach 86 08 20
81635 München / DE
Former [2008/35]Forstmeyer, Dietmar
BOETERS & LIECK Oberanger 32
80331 München / DE
Former [2008/14]Forstmeyer, Dietmar
BOETERS & LIECK Oberanger 32
80331 München / DE
Application number, filing date06776333.420.07.2006
[2014/46]
WO2006EP07177
Priority number, dateDE2005103394320.07.2005         Original published format: DE102005033943
[2008/14]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2007009801
Date:25.01.2007
Language:DE
[2007/04]
Type: A2 Application without search report 
No.:EP1904029
Date:02.04.2008
Language:DE
The application published by WIPO in one of the EPO official languages on 25.01.2007 takes the place of the publication of the European patent application.
[2008/14]
Type: B1 Patent specification 
No.:EP1904029
Date:26.01.2011
Language:DE
[2011/04]
Type: B2 New European patent specification 
No.:EP1904029
Date:12.11.2014
Language:DE
[2014/46]
Search report(s)International search report - published on:EP21.06.2007
ClassificationIPC:A61K9/00, A61K9/70, A61K31/551, A61P25/18
[2008/14]
CPC:
A61K9/006 (EP,US); A61K31/551 (EP,US); A61K31/5513 (EP,US);
A61K9/0056 (EP,US); A61P25/00 (EP); A61P25/18 (EP);
A61P25/22 (EP); A61K9/7007 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/14]
TitleGerman:NICHT-AUSSPUCKBARER, ORALER, SCHNELL-ZERFALLENDER FILM ENTHALTEND OLANZAPIN[2014/46]
English:ORAL, QUICKLY DISINTEGRATING FILM, WHICH CANNOT BE SPIT OUT, CONTAINING OLANZAPIN[2014/46]
French:FILM A DECOMPOSITION RAPIDE, QUI EST ORAL ET NE DEGORGE PAS COMPRENANT DE L'OLANZAPINE[2014/46]
Former [2008/14]NICHT-AUSSPUCKBARER, ORALER, SCHNELL-ZERFALLENDER FILM FÜR EIN NEUROLEPTIKUM
Former [2008/14]ORAL, QUICKLY DISINTEGRATING FILM, WHICH CANNOT BE SPIT OUT, FOR A NEUROLEPTIC DRUG
Former [2008/14]FILM A DECOMPOSITION RAPIDE, QUI EST ORAL ET NE DEGORGE PAS DESTINE A UN NEUROLEPTIQUE
Entry into regional phase01.02.2008National basic fee paid 
01.02.2008Designation fee(s) paid 
01.02.2008Examination fee paid 
Examination procedure09.02.2007Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.02.2008Examination requested  [2008/14]
23.06.2008Despatch of a communication from the examining division (Time limit: M06)
06.02.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
01.04.2009Reply to a communication from the examining division
09.09.2009Despatch of a communication from the examining division (Time limit: M08)
11.05.2010Reply to a communication from the examining division
27.05.2010Despatch of a communication from the examining division (Time limit: M01)
15.06.2010Reply to a communication from the examining division
22.09.2010Communication of intention to grant the patent
10.12.2010Fee for grant paid
10.12.2010Fee for publishing/printing paid
Opposition(s)Opponent(s)01  26.10.2011  03.11.2011  ADMISSIBLE
MonoSol Rx, LLC
30 Technology Drive
Warren, NJ 07059 / US
Opponent's representative
Nash, David Allan, et al, et al
Haseltine Lake LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
 02  26.10.2011  10.11.2011  ADMISSIBLE
Labtec GmbH
Raiffeisenstrasse 4
40764 Langenfeld / DE
Opponent's representative
von Renesse, Dorothea, et al, et al
König-Szynka-Tilmann-von Renesse
Patentanwälte Partnerschaft mbB
Postfach 11 09 46
40509 Düsseldorf / DE
 [N/P]
Former [2011/48]
Opponent(s)01  26.10.2011    ADMISSIBLE
MonoSol Rx, LLC
30 Technology Drive
Warren, NJ 07059 / US
Opponent's representative
Nash, David Allan
Haseltine Lake LLP Redcliff Quay 120 Redcliff Street Bristol
BS1 6HU / GB
 02  26.10.2011    ADMISSIBLE
Labtec GmbH
Raiffeisenstrasse 4
40764 Langenfeld / DE
Opponent's representative
Von Renesse, Dorothea
König Szynka Tilmann von Renesse Patentanwälte Partnerschaft Lohengrinstrasse 11
40549 Düsseldorf / DE
30.11.2011Invitation to proprietor to file observations on the notice of opposition
06.06.2012Reply of patent proprietor to notice(s) of opposition
09.12.2013Date of oral proceedings
03.01.2014Despatch of minutes of oral proceedings
07.02.2014Despatch of interlocutory decision in opposition
12.06.2014Legal effect of interlocutory decision in opposition
17.07.2014Despatch of communication that the patent will be maintained as amended
01.10.2014Fee for printing new specification paid
Appeal following opposition15.04.2014Appeal received No.  T0925/14
12.06.2014Result of appeal procedure: appeal of the proprietor withdrawn
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
01.04.2009Request for further processing filed
Fees paidRenewal fee
31.03.2008Renewal fee patent year 03
10.07.2009Renewal fee patent year 04
14.07.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY26.01.2011
CZ26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
IE26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
LU20.07.2011
MC31.07.2011
[2015/22]
Former [2011/47]CY26.01.2011
DK26.01.2011
EE26.01.2011
FI26.01.2011
IE26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
Former [2011/39]CY26.01.2011
FI26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
Former [2011/36]GR27.04.2011
IS26.05.2011
Cited inInternational search[A]EP0180364  (RECKITT & COLMANN PROD LTD [GB]) [A] 1-30 * the whole document *;
 [X]EP0441333  (SHOWA PHARM CHEM IND [JP]) [X] 1,2,4-8,10,13,14,18,20-24,26-30 * page 4, line 56 - line 57 * * page 6; example 1 * * claims 1-6 *;
 [X]WO0045798  (ORTHO MCNEIL PHARM INC [US]) [X] 1,2,4-10,13,18-23,26,27,29,30 * example 1 *;
 [A]WO0130288  (ANESTA CORP [US]) [A] 1-30 * example 2 *;
 [DA]WO0170194  (WARNER LAMBERT CO [US]) [DA] 1-30* the whole document *;
 [Y]WO2004091585  (SYNTHON BV [NL], et al) [Y] 1-30 * page 8, line 20 - line 21 * * examples 1-21 * * claims 1-32 *;
 [Y]WO2004096193  (WARNER LAMBERT CO [US], et al) [Y] 1-30 * page 6, line 16 - line 25 * * page 8, line 14 * * page 9, line 14 - line 16 * * page 15, line 15 - page 16, line 6 * * claims 1-14 *;
 [DA]US2004247649  (PEARCE TONY M [US], et al) [DA] 1-30 * page 9, paragraph 138 * * page 19, paragraphs 276-285 *
OppositionUS2005118217
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.